NCT03293407
- Conditions
- Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +4 more
- Locations
-
- Many Locations Multiple Locations, Germany
Clinical trial condition
Hypertension, Pulmonary
Explore clinical trials studying Hypertension, Pulmonary. Study availability and eligibility vary by location and protocol.
121 public trials
5 recruiting studies
Hypertension, Pulmonary trial results
NCT01642407
- Conditions
- Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +4 more
- Locations
-
- Kitasato University Hospital Sagamihara, Kanagawa, Japan
- Osaka University Hospital Suita, Osaka, Japan
- Toho University Omori Medical Center Ōta-ku, Tokyo, Japan
- National Center for Child Health and Development Setagaya-ku, Tokyo, Japan
Completed
Sildenafil IV Bolus Study
NCT00800592
- Conditions
- Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +3 more
- Locations
-
- Pfizer Investigational Site Brussels, Belgium
NCT00644605
- Conditions
- Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +3 more
- Locations
-
- Pfizer Investigational Site Birmingham, Alabama, United States
- Pfizer Investigational Site Birmingham, Alabama, United States
- Pfizer Investigational Site Birmingham, Alabama, United States
- Pfizer Investigational Site La Jolla, California, United States
NCT04459364
- Conditions
- COVID, Cardiovascular Diseases, Hypertension, +5 more
- Locations
-
- Karolinska University Hospital Stockholm, Sweden
Completed
Chronic Clinical Effect of Acetazolamide
NCT02755298
- Conditions
- Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +3 more
- Locations
-
- University Hospital Zurich Zurich, Switzerland
NCT02744339
- Conditions
- Cardiovascular Diseases, Heart Failure With Normal Ejection Fraction, Hypertension, +4 more
- Locations
-
- Medical University of Vienna Vienna, Austria
NCT01406327
- Conditions
- Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +3 more
- Locations
-
Not specified
Completed
Relative Bioavailability Study of Marketed and Lower Dose Ambrisentan in Healthy Adult Participants
NCT04095286
- Conditions
- Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +4 more
- Locations
-
- GSK Investigational Site Cambridge, Cambridgeshire, United Kingdom
NCT03177603
- Conditions
- Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +4 more
- Locations
-
- GSK Investigational Site Pittsburgh, Pennsylvania, United States
- GSK Investigational Site Dallas, Texas, United States
- GSK Investigational Site Heidelberg, Baden-Wurttemberg, Germany
- GSK Investigational Site Cologne, North Rhine-Westphalia, Germany